144 related articles for article (PubMed ID: 9469594)
1. Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I.
Pussinen PJ; Jauhiainen M; Metso J; Pyle LE; Marcel YL; Fidge NH; Ehnholm C
J Lipid Res; 1998 Jan; 39(1):152-61. PubMed ID: 9469594
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I.
Jauhiainen M; Huuskonen J; Baumann M; Metso J; Oka T; Egashira T; Hattori H; Olkkonen VM; Ehnholm C
J Lipid Res; 1999 Apr; 40(4):654-64. PubMed ID: 10191289
[TBL] [Abstract][Full Text] [Related]
3. ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion.
Pussinen PJ; Jauhiainen M; Ehnholm C
J Lipid Res; 1997 Jan; 38(1):12-21. PubMed ID: 9034196
[TBL] [Abstract][Full Text] [Related]
4. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive.
Oka T; Kujiraoka T; Ito M; Egashira T; Takahashi S; Nanjee MN; Miller NE; Metso J; Olkkonen VM; Ehnholm C; Jauhiainen M; Hattori H
J Lipid Res; 2000 Oct; 41(10):1651-7. PubMed ID: 11013307
[TBL] [Abstract][Full Text] [Related]
5. Oxidative modification of HDL3 in vitro and its effect on PLTP-mediated phospholipid transfer.
Huuskonen J; Olkkonen VM; Jauhiainen M; Sareneva T; Somerharju P; Ehnholm C
Biochim Biophys Acta; 1998 Mar; 1391(2):181-92. PubMed ID: 9555005
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.
Lusa S; Jauhiainen M; Metso J; Somerharju P; Ehnholm C
Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):275-82. PubMed ID: 8546695
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E activates the low-activity form of human phospholipid transfer protein.
Jänis MT; Metso J; Lankinen H; Strandin T; Olkkonen VM; Rye KA; Jauhiainen M; Ehnholm C
Biochem Biophys Res Commun; 2005 May; 331(1):333-40. PubMed ID: 15845396
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion.
Huuskonen J; Olkkonen VM; Ehnholm C; Metso J; Julkunen I; Jauhiainen M
Biochemistry; 2000 Dec; 39(51):16092-8. PubMed ID: 11123937
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in prebeta-HDL generation.
Jaari S; van Dijk KW; Olkkonen VM; van der Zee A; Metso J; Havekes L; Jauhiainen M; Ehnholm C
Comp Biochem Physiol B Biochem Mol Biol; 2001 Apr; 128(4):781-92. PubMed ID: 11290460
[TBL] [Abstract][Full Text] [Related]
10. Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins.
Cheung MC; Albers JJ
J Lipid Res; 2006 Jun; 47(6):1315-21. PubMed ID: 16520487
[TBL] [Abstract][Full Text] [Related]
11. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
[TBL] [Abstract][Full Text] [Related]
12. Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity.
Huuskonen J; Ekström M; Tahvanainen E; Vainio A; Metso J; Pussinen P; Ehnholm C; Olkkonen VM; Jauhiainen M
Atherosclerosis; 2000 Aug; 151(2):451-61. PubMed ID: 10924722
[TBL] [Abstract][Full Text] [Related]
13. PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma.
Siggins S; Jauhiainen M; Olkkonen VM; Tenhunen J; Ehnholm C
J Lipid Res; 2003 Sep; 44(9):1698-704. PubMed ID: 12810820
[TBL] [Abstract][Full Text] [Related]
14. Influence of the electrostatic charge of lipoprotein particles on the activity of the human plasma phospholipid transfer protein.
Desrumaux C; Athias A; Masson D; Gambert P; Lallemant C; Lagrost L
J Lipid Res; 1998 Jan; 39(1):131-42. PubMed ID: 9469592
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to the carboxyl terminus of human apolipoprotein A-I. The putative cellular binding domain of high density lipoprotein 3 and carboxyl-terminal structural homology between apolipoproteins A-I and A-II.
Allan CM; Fidge NH; Kanellos J
J Biol Chem; 1992 Jul; 267(19):13257-61. PubMed ID: 1377682
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies specific for different regions of human apolipoprotein A-I. Characterization of an antibody that does not bind to a genetic variant of apoA-I (Glu----136 Lys).
Ehnholm C; Lukka M; Rostedt I; Harper K
J Lipid Res; 1986 Dec; 27(12):1259-64. PubMed ID: 2435827
[TBL] [Abstract][Full Text] [Related]
17. Plasma phospholipid transfer protein-mediated reactions are impaired by hypochlorite-modification of high density lipoprotein.
Pussinen PJ; Metso J; Keva R; Hirschmugl B; Sattler W; Jauhiainen M; Malle E
Int J Biochem Cell Biol; 2003 Feb; 35(2):192-202. PubMed ID: 12479869
[TBL] [Abstract][Full Text] [Related]
18. Assignment of the binding site for haptoglobin on apolipoprotein A-I.
Spagnuolo MS; Cigliano L; D'Andrea LD; Pedone C; Abrescia P
J Biol Chem; 2005 Jan; 280(2):1193-8. PubMed ID: 15533931
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human A-I apolipoprotein and characterisation of cyanogen bromide fragments of apoA-I.
Fidge N; Morrison J; Nugent T; Tozuka M
Biochim Biophys Acta; 1989 May; 1003(1):84-90. PubMed ID: 2469474
[TBL] [Abstract][Full Text] [Related]
20. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ
Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
